Use of drifts and PLS for the determination of polymorphs of piroxicam alone and in combination with pharmaceutical excipients: a technical note.
作者信息
Tantishaiyakul Vimon, Permkam Pattakarn, Suknuntha Krit
机构信息
Department of Pharmaceutical Chemistry, Faculty of Pharmaceutical Sciences, Prince of Songkla University, Hat-Yai, Songkhla 90112, Thailand.
出版信息
AAPS PharmSciTech. 2008;9(1):95-9. doi: 10.1208/s12249-007-9003-y. Epub 2008 Jan 15.
Abstract
摘要
相似文献
1
Use of drifts and PLS for the determination of polymorphs of piroxicam alone and in combination with pharmaceutical excipients: a technical note.
AAPS PharmSciTech. 2008;9(1):95-9. doi: 10.1208/s12249-007-9003-y. Epub 2008 Jan 15.
2
Influence of operational variables on properties of piroxicam pellets prepared by extrusion-spheronization: a technical note.
AAPS PharmSciTech. 2007 Mar 9;8(1):20. doi: 10.1208/pt0801020.
3
Role of excipients on solid-state properties of piroxicam during processing.
J Pharm Sci. 2012 Mar;101(3):1202-11. doi: 10.1002/jps.23014. Epub 2011 Dec 9.
4
A new method for a quantitative determination of piroxicam in pharmaceutical formulations using FT-IR spectrometry.
Antiinflamm Antiallergy Agents Med Chem. 2012;11(3):262-6. doi: 10.2174/1871523011202030262.
5
Vibrational spectroscopic and ultrasound analysis for in-process characterization of high-density polyethylene/polypropylene blends during melt extrusion.
Appl Spectrosc. 2005 May;59(5):611-9. doi: 10.1366/0003702053946001.
6
Formulation strategy and evaluation of nanocrystal piroxicam orally disintegrating tablets manufacturing by freeze-drying.
Int J Pharm. 2014 Jun 5;467(1-2):27-33. doi: 10.1016/j.ijpharm.2014.03.047. Epub 2014 Mar 26.
7
Calibration models for the vinyl acetate concentration in ethylene-vinyl acetate copolymers and its on-line monitoring by near-infrared spectroscopy and chemometrics: use of band shifts associated with variations in the vinyl acetate concentration to improve the models.
Appl Spectrosc. 2005 Jul;59(7):912-9. doi: 10.1366/0003702054411571.
8
Monitoring of multiple solid-state transformations at tablet surfaces using multi-series near-infrared hyperspectral imaging and multivariate curve resolution.
Eur J Pharm Biopharm. 2015 Jun;93:224-30. doi: 10.1016/j.ejpb.2015.03.034. Epub 2015 Apr 20.
9
Preparation and evaluation of solid dispersions of piroxicam and Eudragit S100 by spherical crystallization technique.
Drug Dev Ind Pharm. 2010 Aug;36(8):917-25. doi: 10.3109/03639040903585127.
10
Determination of the percentage of homopolymer component in Ziegler/Natta catalyst linear low-density polyethylene resins using high-temperature cell Fourier transform infrared and partial least squares quantitative analysis technique.
Appl Spectrosc. 2005 Mar;59(3):300-4. doi: 10.1366/0003702053585435.
引用本文的文献
1
Small is Powerful: Demonstration of the Impact of Nanoformed Piroxicam in a Controlled Clinical Study.
Pharm Res. 2023 Oct;40(10):2317-2327. doi: 10.1007/s11095-023-03624-8. Epub 2023 Nov 1.
2
Electrospun Gelatin Nanocontainers for Enhanced Biopharmaceutical Performance of Piroxicam: In Vivo and In Vitro Investigations.
Int J Nanomedicine. 2020 Nov 10;15:8819-8828. doi: 10.2147/IJN.S271938. eCollection 2020.
3
Characterization of cimetidine-piroxicam coprecipitate interaction using experimental studies and molecular dynamic simulations.
AAPS PharmSciTech. 2010 Jun;11(2):952-8. doi: 10.1208/s12249-010-9461-5. Epub 2010 May 29.
4
Crystal structure transformations and dissolution studies of cimetidine-piroxicam coprecipitates and physical mixtures.
AAPS PharmSciTech. 2009;10(3):789-95. doi: 10.1208/s12249-009-9263-9. Epub 2009 Jun 12.
本文引用的文献
1
An accurate quantitative analysis of polymorphs based on artificial neural networks.
Colloids Surf B Biointerfaces. 2006 May 1;49(2):153-7. doi: 10.1016/j.colsurfb.2006.03.012. Epub 2006 Apr 18.
2
Dehydration kinetics of piroxicam monohydrate and relationship to lattice energy and structure.
J Pharm Sci. 2004 Dec;93(12):3013-26. doi: 10.1002/jps.20191.
3
Phase transformation considerations during process development and manufacture of solid oral dosage forms.
Adv Drug Deliv Rev. 2004 Feb 23;56(3):371-90. doi: 10.1016/j.addr.2003.10.009.
4
Characterization of piroxicam crystal modifications.
Int J Pharm. 2003 Apr 30;256(1-2):3-15. doi: 10.1016/s0378-5173(03)00057-7.
5
Quantitative analysis of polymorphic mixtures of ranitidine hydrochloride by Raman spectroscopy and principal components analysis.
Eur J Pharm Biopharm. 2002 Nov;54(3):337-41. doi: 10.1016/s0939-6411(02)00113-3.
6
Determination of polymorphic forms of ranitidine-HCl by DRIFTS and XRPD.
J Pharm Biomed Anal. 2001 Jul;25(5-6):741-50. doi: 10.1016/s0731-7085(01)00375-2.
7
Comparative efficacy and safety of nimesulide versus piroxicam in osteoarthritis with special reference to chondroprotection.
Am J Ther. 1999 Jul;6(4):191-7. doi: 10.1097/00045391-199907000-00003.
8
Evaluation of solid-state forms present in tablets by Raman spectroscopy.
J Pharm Sci. 2000 Oct;89(10):1342-53. doi: 10.1002/1520-6017(200010)89:10<1342::aid-jps12>3.0.co;2-x.
9
Physicochemical characterization of indomethacin polymorphs and the transformation kinetics in ethanol.
Chem Pharm Bull (Tokyo). 1985 Aug;33(8):3447-55. doi: 10.1248/cpb.33.3447.
10
Effect of compressional forces on piroxicam polymorphs.
J Pharm Pharmacol. 1992 Aug;44(8):678-81. doi: 10.1111/j.2042-7158.1992.tb05494.x.
Zotero 插件